Interactive Case Studies with the Experts: Improving VTE Prophylaxis in Orthopaedic Surgery
Faculty: Victor F. Tapson, MD, Andrew F. Shorr, MD, MPH, Vincent D. Pellegrini, Jr., MD
Format: Webcast
Credit Available: a maximum of 0.75 AMA PRA Category 1 Credit ™
Course Description: This program addresses key issues in the risk stratification and prevention of venous thromboembolism (VTE) in oncology patients and patients undergoing orthopaedic surgery in the form of two 30-minute interactive case studies. Each case study is presented by a specialist who cares for that subgroup of patients, then discussed with a nationally-recognized VTE expert.
Improving the Care of Patients With Non-Small Cell Lung Cancer: A Practical Guide for Performance Improvement
Faculty: Fred R. Hirsch, MD, PhD, Robert M. Jotte, MD, PhD
Format: Newsletter
Credit Available: a maximum of 1.5 AMA PRA Category 1 Credit ™
Course Description: This implementation guide is one of the educational activities available in Performance Improvement Strategies in Non-Small Cell Lung Cancer. This initiative offers a comprehensive series of activities designed to cover a broad range of topics on non-small cell lung cancer, with the ultimate goal of helping oncologists improve the care of patients with this condition. For additional information on this certified CME initiative or to view the other available activities, visit www.pi-iq.com/lungcancer.
Managing Pain in the Military Setting: Unique Challenges and Practical Strategies
Faculty: Gerry Q. Greenfield, Jr., MD, Wayne B. Jonas, MD, Randall J. Malchow, MD
Format: Newsletter
Credit Available: a maximum of 1.0 AMA PRA Category 1 Credit ™
Course Description: In September 2009, the American Academy of Pain Management and Med-IQ convened a roundtable meeting to discuss the unique nature of pain management in the military setting. Roundtable faculty exchanged ideas in an informative discussion about current challenges in treating wounded servicemembers, traditional and novel approaches to pharmacologic therapy, integrative approaches to help prevent acute pain from progressing to chronic pain, and strategies for transitioning care. This article offers an overview of the discussion and expands upon key topics with support from current medical literature.
CLINICAL UPDATE: Risk Assessment and Prophylaxis of Venous Thromboembolic Disease in Cancer Patients
Faculty: Agnes Y.Y. Lee, MD, MSc, FRCPC, William J. Gradishar, MD, Alok A. Khorana, MD, FACP, Jorge E. Cortes, MD
Format: Webcast
Credit Available: a maximum of 1.0 AMA PRA Category 1 Credit ™
Course Description: The purpose of this program is to address key issues in the risk stratification and prevention of venous thromboembolism (VTE) in oncology patients in the form of a 60-minute panel discussion. The panel is chaired by a nationally-recognized VTE expert, and consist of a breast cancer specialist, a GI cancer specialist, and a hematologist.
The implications of recent clinical data and updated ASCO treatment guidelines for VTE risk assessment and prophylaxis strategies for this high-risk patient population are discussed by the panel, and recently released data from the ASCO 2009 meeting are included in the discussion where appropriate.
Preventing Venous Thromboembolism in Orthopedic Surgery Patients: Evolving Guidelines and Standards of Care
Faculty: Michael H. Huo, MD, Carlos Jerjes-Sánchez Díaz, MD, Anne Jacobson, MPH
Format: Newsletter
Credit Available: a maximum of 1.0 AMA PRA Category 1 Credit ™
Course Description: This newsletter focuses on evolving trends and evidence-based strategies in VTE prophylaxis in the orthopedic surgery setting. It discusses the challenge of incorporating recently published guideline recommendations from the American College of Chest Physicians (ACCP) and the American Academy of Orthopaedic Surgeons (AAOS), as well as standards of care for VTE that have been mandated over the past several years. An in-depth discussion of strategies to prevent VTE is also included, with an overview of current and emerging options for thromboprophylaxis.